Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-3-22
pubmed:abstractText
Gemcitabine is a nucleoside analogue with activity against solid tumors. Gemcitabine metabolic inactivation is catalyzed by cytidine deaminase (CDA) or, after phosphorylation, by deoxycytidylate deaminase (DCTD). We set out to study the pharmacogenomics of CDA and DCTD.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1794-803
pubmed:dateRevised
2007-12-3
pubmed:meshHeading
pubmed-meshheading:16551864-African Americans, pubmed-meshheading:16551864-Animals, pubmed-meshheading:16551864-COS Cells, pubmed-meshheading:16551864-Cercopithecus aethiops, pubmed-meshheading:16551864-Cytidine Deaminase, pubmed-meshheading:16551864-DCMP Deaminase, pubmed-meshheading:16551864-Deoxycytidine, pubmed-meshheading:16551864-European Continental Ancestry Group, pubmed-meshheading:16551864-Genomics, pubmed-meshheading:16551864-Haplotypes, pubmed-meshheading:16551864-Humans, pubmed-meshheading:16551864-Kinetics, pubmed-meshheading:16551864-Linkage Disequilibrium, pubmed-meshheading:16551864-Pharmacogenetics, pubmed-meshheading:16551864-Polymorphism, Single Nucleotide, pubmed-meshheading:16551864-Recombinant Proteins, pubmed-meshheading:16551864-Sequence Analysis, DNA, pubmed-meshheading:16551864-Transfection
pubmed:year
2006
pubmed:articleTitle
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics.
pubmed:affiliation
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural